Go to nanoparticles.org Home Page Particles 2010
Particles 2010 HomeParticles 2010 Home ProgramProgram Registration InfoRegistration Information Go to Registration FormRegistration Form
Go to Abstracts PageAbstract Submission Hotel InfoHotel Accomodations Go to ExhibitngExhibiting Workshop InfoWorkshops Go to DirectionsDirections
Conference dress code: Business casual

Announcing the PlasmaChem Prizes for best posters, Sunday and Monday!
$500 to each winner!

Over 250 lectures by international authorities!

Particles 2010
Medical/Biochemical Diagnostic, Pharmaceutical, and Drug Delivery Applications of Particle Technology
22-25 May 2010
Regal Sun Resort
Lake Buena Vista, Florida

Courtesy Millenium Technology Prize

Co-Sponsored by

  • Particles Conference
  • European Association of Pharma Biotechnology
  • InForm

Corporate Sponsor

  • NanoSight, Ltd.

Plenary Speakers

    Haruma Kawaguchi (Kanagawa University, Yokohama, Japan)
        Stimuli-responsive fluorescent particles
    Helmuth Möhwald (Max Planck Institute for Colloids and Interfaces)
        Nanocarriers with controlled release for materials and biosciences
    James Adair (Pennsylvania State University)
        Targeting tumors with hybrid nanoparticles

International Organizing Committee

T L. Andresen (Denmark)
J. M. Asua (Spain)
D. Burgess (USA)
K. Caldwell (Sweden)
R. Duncan (UK)
M. El-Sayed (USA)
N. Garti (Israel)
K. Johnston (USA)
H. Kawaguchi (Japan)
J. H. Kim (Korea)
S. Margel (Israel)
H. Möhwald (Germany)
B. Moudgil (USA)
R. Mueller (Germany)
T. Nilsen (USA)
D. Poncelet (France)
M. C. Roco (USA)
P. Rogueda (UK)
J. L. Salager (Venezuela)
S. Simoes (Portugal)
P. T. Spicer (USA)
S. Svenson (USA)
J. Texter (USA), General Chair
D. Thompson (USA)

Particles 2010 is an international conference examining the science, technology, and business aspects of medical/biochemical diagnostic, pharmaceutical, and drug delivery applications of particle technology. Symposia will address diverse topics including nanoparticles, hydrogels, chemical and drug delivery, controlled release, suspensions, inhalation, liposomes, micelles & microemulsions, characterization, gene delivery, siRNA delivery, chemical and biochemical diagnostics, separations, surface modification, critical and supercritical fluid applications, spray drying, emulsions, and multiple emulsions. The conference targets practicing scientists, clinical research physicians, engineers, managers, innovators, and entrepreneurs, and embraces the theme "particles for detection and treatment."

The conference format comprises 5 parallel tracks of over 250 invited and contributed oral papers. Over 100 contributed poster papers will be presented in the two poster sessions.

Corporate Sponsor

  • NanoSight, Ltd.
  • Exhibitors

    Conference Program

    Speakers and Presenters

    Saturday Evening, 22 May 2010
    1800-1930 Opening Reception/Mixer/Exhibition

    Sunday Morning, 23 May 2010
    Session Chair: Andrew Lyon (Georgia Tech)
    1. Plenary 1 - Haruma Kawaguchi (Kanagawa University)
      Stimuli-responsive coloring particles

    0900-1200 Parallel Sessions

    A1 Nanoparticles & Hydrogels; B1 Characterization; C1 Gene & siRNA Delivery; D1 Triggered Release; E1 General Papers

    1135-1200 Special Presentation: 39. Nily Dan; Interfaces Initiatives in the NSF Biology Directorate

    1200-1400 Luncheon/Exhibition

    Sunday Afternoon, 23 May 2010
    1400-1730 Parallel Sessions

    A2 Nanoparticles & Hydrogels; B2 Characterization; F1 Encapsulation & Controlled Release;
    G1 Diagnostics; H1 Toxicology

    1720-1745 Special Presentation: 84. Lucienne Juillerat; NanoImpactNet - An EU FP7 Network

    Sunday Evening, 23 May 2010
    1800-2000 Poster Session P1/Reception/Exhibition

    Monday Morning, 24 May 2010
    Session Chair: Gleb Sukhorukov (Queen Mary College)
    85. Plenary 2 - Helmuth Möhwald (Max Planck Institute for Colloids and Interfaces)
      Nanocarriers with controlled release for materials and biosciences

    0900-1200 Parallel Sessions

    A3 Nanoparticles & Hydrogels; I1 Targeting; C2 Gene & siRNA Delivery;
    G2 Diagnostics & Imaging; J1 Inhalation Therapy

    1200-1400 Luncheon/Exhibition

    Monday Afternoon, 24 May 2010
    1400-1730 Parallel Sessions

    A4 Nanoparticles & Hydrogels; I2 Targeting; F2 Encapsulation & Controlled Release;
    G3 Diagnostics & Imaging; H2 Toxicology

    1705-1730 Special Presentation: 163. Philippe Rogueda; InForm: Integrating the Nanoscale in Formulations

    Monday Evening, 24 May 2010
    1800-1930 Poster Session P2/Reception/Exhibition

    Tuesday Morning, 25 May 2010
    Session Chair: Omid Farokhzad (Brigham and Women's Hospital)
    164. Plenary 3 - James Adair (Pennsylvania State University)
      Targeting tumors with hybrid nanoparticles

    0900-1200 Parallel Sessions

    A5 Nanoparticles & Hydrogels; K1 Surface Modification; L1 Vaccines;
    G4 Diagnostics & Imaging

    1200-1400 Luncheon/Exhibition
    Tuesday Afternoon, 25 May 2010
    1400-1730 Parallel Sessions

    A6 Nanoparticles & Hydrogels; M1 Oral & Transdermal Delivery;
    F3 Encapsulation & Controlled Release; G5 Diagnostics & Imaging

    1730 Conference Ends

    Session A1 (Sunday 0900-1210) Nanoparticle & Hydrogel Synthesis
    Session Chair: Todd Krauss

    0900   2. Atsushi Takahara; Keynote - Characterization of liquid marbles coated with hydrophobic fluoropolymer microparticles
    0930   3. Jean-Francois Berret; A versatile approach for the fabrication of magnetofluorescent nanorods
    0945   4. Gan-Moog Chow; Size and interface effects of upconversion sodium yttrium fluoride (NaYF4) nano-phosphors
    1010   Break
    1030   5. Jesus Santamaria; Gold-silica hybrid nanoparticles for drug delivery and near-infrared hyperthermia
    1055   6. Yukio Nagasaki; Nitroxyl radical-containing nanoparticles for ischemia reperfusion injury
    1120   7. Alexander Couzis; Supramolecular paths for the synthesis of composite hollow particles
    1145   8. Jianjun Cheng; Controlled formulation of polymeric nanoparticles for in vitro and in vivo drug delivery
    1210  End of Session

    Session A2 (Sunday 1400-1755) Nanoparticle & Hydrogel Synthesis
    Session Chair: Sonke Svenson

    1400   40. Ravi Bellamkonda; Multifunctional imaging nanocarriers for angiography and personalized medicine
    1425   41. Elena Dormidontova; Nanoparticle targeting design optimization by computer simulations
    1450   42. Sonke Svenson; Polymeric nanoparticles of camptothecin "€“ Early clinical development of IT-101
    1515   43. Robert O. Williams III; Formulation and characterization of itraconazole nanoparticles made by advanced evaporative precipitation into aqueous solution
    1540  Break
    1600   44. Brian Windsor; Benefits of nanostructured compositions made by rapid freezing to drug delivery
    1625   45. Artur Cavaco-Paulo; Protein based nano- and microspheres for medical applications
    1640   46. Yu Huang; Specific peptide mediated nanoparticle sysnthesis
    1705   47. Srinivas Sridhar; Nanoplatforms for nanomedicine
    1730   48. Satoshi Sakamoto; Development of highly functionalized magnetic beads applicable to drug discovery research
    1755  End of Session

    Session A3 (Monday 0900-1225) Nanoparticle & Hydrogel Synthesis
    Session Chair: Kui Yu

    0900   86. Chuan-Jian Zhong; Keynote - Magnetic and core-shell nanoparticles for probing and delivering biomolecules
    0930   87. Si Amar Dahoumane; Bio-controlled synthesis of gold nanoparticles using micro-algae as bioreactors: Control of size and shape and reaction kinetics
    0945   88. Brian Amsden; BMP-6 release from stericly stabilized microspheres prepared from low melting point poly(caprolactone-co-trimethylene carbonate)
    1010  Break
    1030   89. Luis Brito; TLR agonists in nanoemulsions for adjuvant delivery
    1055   90. Todd Krauss; Insights into synthesis of ultra-small semiconductor quantum dots
    1120   91. Steve Little; Polymeric particles as a platform for biomimetic drug delivery
    1145   92. Carmen Gruber-Traub; Biomimetic particles: Concept, design and applications in biotechnology and biomedicine
    1210   93. Hadas Skaat; Synthesis and characterization of magnetic core-shell nanoparticles for inhibition or acceleration of insulin and amyloid-beta fibril formation
    1225  End of Session

    Session A4 (Monday 1400-1730) Nanoparticle & Hydrogel Synthesis
    Session Chair: Heinrich Hofmann

    1400   120. L. Andrew Lyon; Keynote - Designed core/shell nanogels for controlled release
    1430   121. Frank Scheffold; Brushlike interactions between thermoresponsive microgel particles
    1445   123. Matthew Yates; Hydrogel nanoparticles as carriers for peptides and proteins
    1510   124. Paul Russo; Polypeptide-silica particles: Hierarchy in structure and function
    1535  Break
    1555   125. Heiko Schiffter; Biodegradable nanoparticles for drug delivery prepared by a new spray-drying process
    1610   127. Afsaneh Lavasanifar; Engineered polymeric micelles for overcoming drug resistance in cancer
    1635   126. Anna-Lena Kjøniksen; Thermosensitive hydroxyethylcellulose-graft-poly(N-isopropylacrylamide) nanoparticles
    1650   128. Daniel Crespy; Nanparticles from miniemulsion relevant for biomedical applications with different chemistry, sizes, and shapes
    1705   129. Shirui Mao; Polymeric micelles as carriers for peroral administration of hydroxycamptothecin
    1730  End of Session

    Session A5 (Tuesday 0900-1215) Nanoparticle & Hydrogel Synthesis Session Chair: Hong Yang

    0900   166. Horacio Cabral; Keynote - Supra-molecular structures as nanocarriers for drug delivery - Challenges to smart molecular therapy
    0930   167. Ulyana Angel; Applications of sonochemically produced proteinaceous microspheres
    0945   168. Nguyen TK Thanh; Recent developments in the synthesis of magnetic nanoparticles for biomedical application
    1010  Break
    1030   169. Kui Yu; Development of photoluminescent colloidal semiconductor nanocrystals aiming at bio-oriented applications
    1055   170. Lian-Yan Wang; Preparation and application of alginate-chitosan microspheres with narrow size distribution for oral delivery of insulin
    1110   171. Stephan Barcikowski; Design of individual gold nanomarker-bioconjugates by laser ablation without chemical precursors or ligand exchange
    1135   172. Andreas Taubert; Multifunctional metal nanoparticles - Synthesis, self-assembly, and biological response
    1200   173. Jie Wu; Preparation of uniform-sized quaternized chitosan micro- and nano-spheres by combining membrane emulsification and thermal-gelation
    1215  End of Session

    Session A6 (Tuesday 1400-1720) Nanoparticle & Hydrogel Synthesis
    Session Chair: Horacio Cabral

    1400   195. Hong Yang; Keynote - Engineered nanostructures for biological applications
    1430   196. Rita El-Khouri; Continuous preparation of gold nanoparticles
    1445   197. Robert DeLong; Biomolecular and stabilizing interactions of Au, MnO and ZnO nanomaterials with DNA, RNA and proteins
    1510   198. Andreas Hütten; Magnetic particles: From sensor to microfluidic applications
    1535   Break
    1555   199. Roongnapa Suedee; Nanoparticle-on-microsphere molecularly imprinted polymers as drug delivery systems
    1620   200. Tomoaki Hino; Improvement of dissolution property of poorly water soluble drugs by adsorption on the surface of curdlan particles
    1635   201. Manish Arora; Biocompatible micro and nano-particles for controlled cavitation inception in water and procine blood
    1650   202. Nurettin Sahiner; Post modification of hyaluronic acid based particles and composites for biomedical applications
    1705   203. X. F. Zhang; Synthesis of mesoporous silica nanopartilces coupled with Fe3O4 or Fe3O4-Au cores as drug carriers
    1720  End of Session
    Session B1 (Sunday 0900-1210) Characterization
    Session Chair: Dave Nicoli

    0900   9. Bob Carr; Keynote - Simultaneous real-time multiparameter analysis of bionanoparticles in liquids
    0930   10. Ian Block; Particle characterization in turbid systems using 3D cross-correlation techniques
    0945   11. Mark Bumiller; Image analysis as a tool for particle characterization in the pharmaceutical industry
    1010  Break
    1030   12. Hilde Jans; Dynamic light scattering as a powerful tool for gold nanoparticle characterization and biomolecular binding studies
    1045   13. Judith Kuntsche; Asymmetrical flow field-flow fractionation for the characterization of lipid-based colloidal formulations
    1110   14. Giacomo Perfetti; X-ray tomography and image analysis as complementary methods for morphological characterization and coating thickness measurement of coated particles
    1125   15. Hyonchol Kim; Non-amplified quantitative detection of target biomolecules using metal nanoparticle probe set and FE-SEM
    1150   16. Byron Cheatham; In vitro hyperspectral imaging of nanoparticles in live cells
    1205   17. Johannes H. Kindt; Quantitative nanoscale mapping of topography and surface mechanical properties
    1220  Session Ends

    Session B2 (Sunday 1400-1745) Characterization
    Session Chair: Bob Carr

    1400   49. David F. Nicoli; New focused-beam SPOS technology reaches below 0.15 μm for challenging particle size applications in biotechnology
    1425   50. David Driscoll; Stability of injectable emulsions: Mean droplet diameter vs. the large-diameter tail
    1450   51. Scott C. Brown; Tissue culture AFM probes, pleural space tribology and the pathogenesis of pneumothorax
    1505   52. Mark A. Poggi; Quantifying in situ changes of nanoscale interactions using quartz crystal microbalance with dissipation monitoring
    1520   53. Sam Yu; Novel techniques for nanoparticle analysis and characterization: Diagnostic, pharmaceutical and drug delivery applications
    1535  Break
    1555   54. Stephen Williams; New developments in magnetic field-flow fractionation for the analysis of magnetic nanoparticles
    1620   55. Yoann Lefeuvre; Laser microrheology for soft materials
    1635   56. Nuttawut Lewpiriyawong; Dielectrophoretic characterization and continuous separation of micro/submicron particles and cells in a PDMS-based microfluidic device with silver-PDMS electrodes
    1650   57. Clemens Helmbrecht; Continuous characterization and separation of single particles by photophoresis
    1705   58. Bieke Van de Broek; Thermo-optical properties of branched gold nanoparticles for hyperthermia tumor treatment
    1720   59. Maria Teresa Celis; Characterization of nano-dispersions
    1745  End of Session
    Session C1 (Sunday 0900-1225) Gene and siRNA Delivery
    Session Chair: Martin Woodle

    0900   18. David H. Thompson; Keynote - Construction of a novel bioresponsive vector system based on beta-6-amino-cyclodextrins and PEG-polyvinyl alcohol)-adamantine host:guest interactions
    0930   19. Yong Wang; The development of gold nanoparticles as a functional delivery system for islet transplant
    20. Yoshiki Katayama; New gene regulation delivery system using intracellular-responsive artificial gene regulator/gene complex for cell-specific therapy and imaging
    1010  Break
    21. Robert J. Lee; Targeted nanoparticles for oligonucleotide delivery
    22. Laurence Navailles; Anionic nucleotide-lipids for in vivo DNA transfection
    23. Jon Preece; Nanoparticulate dual intracellularly degradable peptide vectors for gene delivery
    24. Yasuhiko Tabata; Nanoparticles technology to genetically manipulate the biological functions of stem cells
    25. John Texter; New nanofluid particles for gene delivery
    1225  End of Session

    Session C2 (Monday 0900-1200) Gene and siRNA Delivery
    Session Chair: David Thompson

    101. Francesco Stellacci; Keynote - Cell membrane penetrating particles for RNA delivery
    102. Marc Abrams; Optimizing a lipid-based vehicle for siRNA delivery to liver
    103. Barbara Geusens; Flexible nanosomes (secosomes) enable efficient siRNA delivery in cultured primary skin cells and in the viable epidermis of ex vivo human skin
    1020  Break
    104. Martin Woodle; Keynote - Tissue targeted siRNA nanoparticle therapeutics: The next "antibody"
    105. Chrsitopher Levins; Combinatorial synthesis of materials for nanoparticle based siRNA therapeutics
    106. Zheng-Rong Lu; Targeted multifunctional siRNA delivery systems
    1200  End of Session
    Session D1 (Sunday 0900-1225) Triggered Release
    Session Chair: Thomas Andresen

    0900   26. Kenji Kono; Keynote - Design of multifunctional nanovesicles for temperature-sensitive drug release and imaging
    0930   27. Mark W. Grinstaff; Expansile nanoparticles: Synthesis, characterization, and in vivo efficacy of an acid-responsive polymeric drug delivery system
    0955   28. J. Andrew Mackay; Genetically engineered polypeptosomes
    1020  Break
    1040   29. Samir Mitragotri; Keynote - Red blood cell-mimetic synthetic particles
    1110   30. Robin L. McCarley; Redox-responsive liposome-based delivery systems
    1135   31. Jinming Gao; Micellar nanomedicine for cancer imaging and therapy
    1200   32. Christophe Schatz; Engineering the surface of magnetic nanoparticles by adsorption of double hydrophilic block copolymers
    1225  End of Session
    Session E1 (Sunday 0900-1130) General Papers
    Session Chair: Robert Delong

    0900   33. John Volckens; Development of a system for direct, particle-to-cell deposition at the air-liquid interface in vitro
    0925   34. Kerri-Ann Hue; Targeted extraction of hydrophobic mycotoxins using modified montmorillonite clays
    0945   35. Johannes Kluge; Pharmaceutical micro- and nano-composites by supercritical CO2 extraction of emulsions
    1010  Break
    1035   36. Tommy Horozov; Particle assisted photolighography: Principles and applications
    1050   37. Jonghwi Lee; Structures from electrohydrodynamic jetting and their assembly
    1115   38. Yakov Rabinovich; Role of diffusion kinetics in capillary phenomena
    1130  End of Session
    Session F1 (Sunday 1400-1750) Encapsulation & Controlled Release
    Session Chair: Christophe Lacroix

    1400   60. Nily Dan; Keynote - Colloidosomes for cell encapsulation and drug delivery: Tailoring transport and flux
    1430   61. Dennis Bong; Designed molecular recognition at the lipid-water interface
    1455   62. Mads H. Clausen; Novel lipid conjugated prodrugs for sPLA2 activated liposomal drug delivery
    1420   63. Atoosa Maleki; Thermoresponsive amphiphilic block copolymers for sustained release of hydrophobic pharmaceuticals
    1535  Break
    1555   64. Parkson L.-G. Chong; Bipolar tetraether liposomes: Physical properties and applications
    1620   65. Amitav Sanyal; Colloidal microcapsules via directed slf-assembly at the liquid-liquid interface
    1645   66. Elka Touitou; Drug delivery applications with ethosomes
    1710   67. Jonathan R. Howse; Templated vesicle formation and propelled vesicles for enhanced delivery
    1735   68. Daniel Klinger; Novel photodegradable crosslinkers for the preparation of light sensitive microgels
    1750  End of Session

    Session F2 (Monday 1400-1750) Encapsulation & Controlled Release
    Session Chair: Kenji Kono

    1400   138. Christophe Lacroix; Keynote - New in vitro intestinal fermentation models with immobilized human fecal microbiota for diet and drug assessment
    1430   139. Anuj Chauhan; Extended opthalmic drug delivery from contact lens containing particles and barriers
    1455   140. Erhan Altinoglu; Simultaneous near infrared diagnostic imaging and photodynamic therapy of cancer
    1510   141. Shun’chi Kuroda; Bio-nanocapsules for the in vivo pinpoint delivery of nucleic acids and drugs
    1535  Break
    1555   142. Anja Kroeger; Functionalized and tunable nanoparticles for biomedical applications and their interactions with cells
    1610   143. Wei Wei; Preparation of hierarchical hollow CaCO3 particles and their application as anticancer drug carrier
    1625   144. Thomas Scheibel; Spider silk submicroparticles for controlled drug delivery
    1650   145. Pilar Rivera Gil; Intracellular processing of proteins mediated by biodegradable polyelectrolyte capsules
    1705   146. Guanghi Ma; Preparation of uniform-sized microspheres and microcapsules for drug delivery
    1720   147. Uta Riebetanz; Cell-penetrating peptide as surface layer for fast endocytotic uptake of colloidal microcarriers by cells
       148. Emilia Pisani; Sustained release nanoparticles for oral administration of irinotecan
    1750  End of Session

    Session F3 (Tuesday 1400-1735) Encapsulation & Controlled Release
    Session Chair: Thomas Scheibel

    1400   211. Gleb Sukhorukov; Keynote - Intracellular delivery of polyelectrolyte capsules for on-site sensing and manipulation
    1430   212. Eric Simone; Filamentous therapeutic enzyme encapsulating polymer nanocarriers
    1455   213. To Ngai; Stimulus-sensitive particles at liquid interfaces: Self-assembly and stabilizing properties
    1510   214. Paula Pescador; Nucleolipid-based microtubes for storage and delivery of bioactive compounds
    1525   215. Kosta Ladavac; Foam-templated functional particles
    1540  Break
    1600   216. Frank Boury; Calcium carbonate microparticles formulated in supercritical CO2: Application for protein encapasulation
    1625   217. Dara Van Gough; Size selection: Programming access to encapsulated biomolecules in mesoporous hollow spheres
    1650   218. Jennifer S. Hong; Microfluidic directed assembly of liposome-hydrogel hybrid nanoparticles
    1705   219. Aysegul Aygun; Stability and controlled release mechanisms of biocides encapsulated in liposomes
    1720   220. Viviano Vergaro; Halloysite nanotubes and nanocolloids: High payload drug nanocarriers
    1735  End of Session
    Session G1 (Sunday 1400-1705) Diagnostics & Imaging
    Session Chair: Shlomo Margel

    1400   69. Ulrich Wiesner; Keynote - C Dots: Fluorescent core-shell silica nanoparticles for bioimaging and nanomedicine
    1430   70. Clémence Sicard; Gold production by silica-entrapped photosyntheitic organisms: A "living" bio-hybrid material
    1445   71. Sandra Rosenthal; Lipid rafts modulate membrane mobility of serotonin transporters in living serotonergic neurons revealed by single quantum dot
    1510   72. Qun Huo; NanoDLSay for broad-based immunoassays
    1535  Break
    1555   73. Wolfgang Parak; Keynote - Ion sensing and delivery with nano- and microparticles
    1625   74. Si-Shen Feng; Nanoparticles of biodegradable polymers for cancer detection and treatment at its earliest stage
    1650   75. Eric K. Dufek; Surface enhanced Raman scattering as a readout strategy for immunodetection
    1705  End of Session

    Session G2 (Monday 0900-1210) Diagnostics & Imaging
    Session Chair: Uhlrich Wiesner

    0900   107. Heinrich Hofmann; Keynote - SPION as a diagnostic tool at the molecular level
    0930   108. Lionel Maurizi; New method of SPION synthesis: In vitro and in vivo biological applications as an MRI contrast agent
    0945   109. Thomas L. Andresen; Nanoparticles for in vivo imaging
    1010  Break
    1030   110. Lily Yang; Theranostic nanoparticles for targeted therapy and imaging of breast and pancreatic cancers
    1055   111. David Cliffel; Epitope mapping of protein binding domains using nanoparticle display
    1120   112. Tokuji Miyashita; Hybrid nano assemblies of polymer nanosheets with metal nanoparticles
    1145   113. Shlomo Margel; Engineering of new iron oxide and iodinated nanoparticles for biomedical applications: Florescence, MRI & CT contrast agents, cancer therapy and diagnostics and therapy of neurodegenerative disorders
    1210  End of Session

    Session G3 (Monday 1400-1700) Diagnostics & Imaging
    Session Chair: Wolfgang Parak

    1400   149. Vince Rotello; Keynote - Protein, bacteria, and mammalian cell sensing using particle-polymer complexes
    1430   150. Swadeshmukul Santra; Ultra-small chitosan based fluorescent and paramagnetic nanoparticles for biomedical applications
    1455   151. Carsten Gellermann; ORMOBEAD"® RARE "€“ First generation of luminescent nanoparticles for biomedical applications
    1510   152. Marcus Yaffee; 3D quantitative analysis of new bacteria-specific nanoprisms
    1535  Break
    1555   153. Mizuo Maeda; Non-cross-linking aggregation of DNA-carrying nanoparticles for ion, chemical and gene sensing
    1620   154. Ching-An Peng; Rapid antiviral assay using QD-tagged virus as imaging nanoprobe
    1635   155. Rex Hjelm; The role of particles in polymer composite properties
    1635   156. Niagara Muhammad Idris; Upconverting fluorescent nanoparticles for imaging and photodynamic therapyes
    1700  End of Session

    Session G4 (Tuesday 0900-1210) Diagnostics & Imaging
    Session Chair: Vince Rotello

    0900   188. Keith P. Johnston; Keynote - Controlled assembly of biodegradable multifunctional nanoclusters for biomedical imagin and therapy
    0930   189. Chantal Paquet; Clusters of superparamagnetic nanoparticles enapsuated in a polymer hydrogel for MRI imaging
    0945   190. Xiaohu Gao; Imaging and therapy with multifunctional nanoparticles
    1010  Break
    1030   191. Naoto Oku; PET imaging for the development of DDS pharmaceutics
    1055   192. Ya Ping Sun; Fluorescent carbon dots for bioimaging and beyond
    1120   193. Evan Unger; Perfluorocarbon microbubbles and nanodroplets for oxygen, drug, gene delivery and sonothrombolysis
    1145   194. Hiroyuki Wada; Preparation of long afterglow nanoparticles for bioimaging
    1210  End of Session

    Session G5 (Tuesday 1400-1655) Diagnostics & Imaging
    Session Chair: Keith Johnston

    1400   221. Gang Ho Lee; Ultra small metal oxide nanoparticles for molecular T1 MR imaging
    1425   222. Anthony McGoron; Multimodal drug delivery for imaging and therapy of cancer using PLGA nanoparticles
    1450   223. >Eva Marie Harth; Functional soft nanosponges for single combination therapy and imaging
    1515   224. Charalambos Kaittanis; From rational design to probe optimization "€“ The role of nanoparticle valency in single cancer cell detection with magnetic relaxation
    1530  Break
    1550   225. Lars Kilaas; Inexpensive methods for producing magnetic and non-magnetic particles and their use in bio and pcetroleum related applications
    1615   226. Ozana Onaca; Polymer nanoreactors for biosensing and controlled delivery of drugs
    1640   227. Ahmed Ibrahim Ali Abdelrahman; Metal-encoded microspheres for mass cytometry: Standards and multiplexed bioassays platforms
    1655  End of Session
    Session H1 (Sunday 1400-1725) Toxicology
    Session Chair: Kenji Yasuda

    1400   76. Kazunari Akiyoshi; Keynote - Development of new protein delivery system by nanogel engineering
    1430   77. Roberta Brayner; Impact of physico-chemical characteristics of nanomaterials interactions with photosynthetic microorganisms in terms of ecotoxicity toxico
    1455   78. Xi Guang Chen; A novel chitosan antibacterial dispersion system with nanotechnology The effects of particle size, coating, and reactivity on cell function
    1510   79. Lucienne Juillerat; Transport of nanoparticles across cellular barriers, the examples of the blood-brain and the digestive barriers
    1535  Break
    1555   80. Gerhard Pütz; CARL and kinetic targeting: A backdoor approach to diminish toxicity of liposomal doxorubicin
    1620   81. Juergen Schnekenburger; Method of standardizaton and comparative in vitro testing of 23 engineered nanoparticles
    1645   82. Marc Schneider; Chitosan/PLGA particles for drug delivery and their cytotoxic profile
    1710   83. Megan Hahn; Cellular applications and effects of nanomaterials
    1725  End of Session

    Session H2 (Monday 1400-1700) Toxicology
    Session Chair: Roberta Braynor

    1400   157. Wendel Wohlleben; Keynote - Characterization and biophysics of particles in the dawn of nanotechnology regulation
    1430   158. Tzung Hsiai; Variations in chemical compositions of ultra fine particles differentially regulate vascular pro-inflammatory states
    1455   159. Qunwei Zhang; The role of hypoxia inducible factor 1α in MMP-2 and MMP-9 production by human monocytes exposed to nickel nanoparticles
    1520   160. Anil K. Suresh; Toxicity evaluation of engineered nanoparticles on Gram-negative and Gram-positive bacteria
    1535  Break
    1555   161. Hussain Saber; Cytotoxicity of nanoparticles based on their unique physicochemical properties
    1620   162. Hicham Chibli; InP and CdSe quantum dots: Synthesis, conjugation, and cytotoxicity
    1635   163. Paolo Caliceti; Gold nanoparticles: Perspectives and opportunities for nanomedicine
    1700  End of Session
    Session I1 (Monday 0900-1200) Targeting
    Session Chair: Si-Shen Feng

    0900   94. Omid Farokhzad; Keynote - Multifunctional polymeric nanoparticles for medical applications
    0930   95. Kate Fitzgerald; Neutrally charged nanospheres as potential candidates for cardiovascular targeting
    0945   96. Zhuo (Georgia) Chen; Ligand specific therapeutic nanoparticles for head and neck cancer targeting
    1010  Break
    1030   97. Volkmar Weissig; Mitochondria-targeted anticancer chemotherapy
    1055   98. Stefano Leporatti; Nanocarriers for cancer therapy
    1110   99. Jin Zhong Zhang; Photothermal ablation therapy of cancer with plasmonic metal nanostructures: A case study using hollow gold nanospheres for carcinoma and melanoma
    1135   100. Tamara Minko; Nanotechnology strategies to overcome limitations in cancer treatment
    1200  End of Session

    Session I2 (Monday 1400-1740) Targeting
    Session Chair: Volkmar Weissig

    1400   130. Roger M. Leblanc; Keynote - Inhibition of amyloid fibrillation by conjugated quantum dots
    1430   131. Mika Lindén; Cell-specific delivery of active cargo to cancer cells using mesoporous silica as carriers
    1455   132. Sangyong Jon; Aptamer-mediated drug delivery for prostate cancer therapy
    1520   133. Seong-Yun Jeong; Preclinical evaluation of Au nanoparticle containing β-lapachone for radiosensitization
    1545  Break
    1600   134. Xiao Yu (Shirley) Wu; Harnessing the synergy of drug combination and nanocarrier to overcome multidrug resistance in breast cancer
    1625   135. Cecelia Sahlgren; Nanotechnolgy for targeted control of signaling pathways in cancer and stem cell differentiation
    1650   136. Hideo Sawada; Preparation and applications of fluoroalkyl end-capped oligomer/silica nanocomposites possessing a potent and selective anti-HIV-1 activity
    1715   137. Glyoong Tae; Functionalized Pluronic-PLGA nanoparticles for growth factor delivery and tumor targeting
    1740  End of Session
    Session J1 (Monday 0900-1150) Inhalation
    Session Chair: Philippe Rogueda

    0900   114. Philippe Rogueda; Keynote - The rheology of solid fine particles
    0930   115. Oksana Olkhovyk; An ingredient-specific particle size characterization of dry powder inhaler with two APIS
    0945   116. Kunn Hadinoto; Antibacterial efficacy of inhalable antibiotic-loaded nanoparticles against biofilm infections by respiratory pathogens
    1010  Break
    1030   117. Robert Sievers; Keynote - Safer delivery of nanoparticles and microparticles of vaccines and pharmaceuticals
    1100   118. Albert Mihranyan; Fractal roughness of particles - New insights
    1125   119. Jim Talton; Nanotherapeutics inhaled and nasal dry-powder platform technologies
    11500  End of Session
    Session K1 (Tuesday 0900-1215) Surface Modification
    Session Chair: Roger Leblanc

    0900   174. J. Manuel Perez; Keynote - Polymer-coated cerium oxide nanoparticles as potential targeted radical scavenging nanoagent
    0925   175. Jacqueline Lessig; Phagocytotic competence of differentiated U937 cells for colloidal drug delivery systems in immune cells
    0945   176. En-Tang Kang; Nanostructured functional particles via atom transfer radical polymerization
    1010  Break
    1030   177. Hedi Mattoussi; Design of modular multifunctional ligands and their use for nanoparticle synthesis and coupling to biomolecules
    1055   178. Tom Dziubla; Controlling biocompatibility of nanoparticles through the application of antioxidant polymers
    1120   179. Koon-Gee Neoh; Surface modification of magnetic nanoparticles for biomedical applications
    1145   180. Tanmay Lele; Nanorods for preventing normal and tumor cell adhesion
    1200   181. Ale Närvänen; Biofunctionalization of mesoporous silicon nanoparticles for targeted peptide delivery
    1215  End of Session
    Session L1 (Tuesday 0900-1155) Vaccine Delivery
    Session Chair: Russell Mumper

    0900   182. Ben Maynor; Keynote - PRINT technology - A versatile platform for delivery of particle therapeutics and vaccines
    0930   185. Mitsuru Akashi; Development of new protein delivery system by nanogel engineering
    0955   184. Thierry Delair; Colloidal chitosan: Toward new vaccine adjuvants
    1020  Break
    1040   185. Russell Mumper; Nanoparticles as multi-epitope HIV protein subunit vaccine delivery systems
    1105   186. Aliasger K. Salem; Biodegradable polymeric particles that co-deliver antigens and adjuvants
    1130   187. Abhinav Acharya; Parallel particle production and cellular arrays for particle-vaccine development and optimization
    1155  End of Session
    Session M1 (Tuesday 1400-1710) Oral & Transdermal Delivery
    Session Chair: Edgar Acosta

    1400   204. Özgen Özer; Keynote - Advances in developing dermal formulations of corticosteroids via lecithin-chitosan nanoparticles
    1430   205. Sheng Qi; An investigation into the interaction of a pharmaceutical water-soluble polymer with bio-relevant
    1445   206. Krassimir Velikov; The effects of droplet size on the kinetics of in vitro lipolysis of lipid-based delivery systems
    1510   207. Masahiro Goto; Transdermal protein delivery using a nano-coating technique for biomolecules
    1535  Break
    1555   208. Edgar Acosta; Self emulsifying and microemulsifying oral delivery systems
    1620   209. Jean-Christophe Jacquier; Carrageenan microgels as responsive nutraceutical delivery systems
    1645   210. Muriel Subirade; Food protein-based material as oral delivery vehicles for nutraceutical products
    1710  Session Ends
    Poster Session P1 (Sunday, 1800-1930)
    Session Chair: John Texter, Eastern Michigan University

    Nanoparticles & Hydrogels
    228. Muriel Subirade; Chitosan nanoparticles inside alginate microparticle for oral delivery of Clostridium botulinum toxin immunoglobulin
    229. Muriel Subirade; Study of beta-lactoglobulin as a potential carrier of folic acid
    230. Keith P. Johnston; Low viscosity highly concentrated dispersions of stable submicron IgG protein particles formed by swift freezing
    231. Teppei Kikuchi; Preparation of water-based magnetite suspension for biomedical application
    232. Sanjay R. Mishra; A green hydrothermal synthesis of magnetic-photoluminescent carbon coated tellurium nanostructures
    233. Peyman Moslemy; Non-invasive delivery of biodegradable drug-containing nanoparticles by ocular iontophoresis
    234. Makato Murakami; Fabrication of surfactant free nanocolloid solution by using ultrafast laser ablation
    235. Jessie Desbiens; Synthesis and characterization of polymer nanoparticles doped with a luminescent europium complex and silver nanoparticles
    236. Astha Malhotra; Microemulsion synthesis of buffer-stable chitosan-PGA hybrid nanoparticles for biomedical applications

    Cancer Therapy
    237. Dabatosh Majumdar; Nanotechnology based targeted cancer prevention and therapy
    238. Wei Wei; Galactosylated nanocrystallites of insoluble anticancer drug for liver targeting therapy
    239. In-Hyun Lee; A duplex oligodeoxynucleotide-dendrimer bioconjugate as a novel delivery vehicle of doxorubicin for in vivo cancer therapy
    240. Frederic Bouyer; Synthesis of silica nanoparticles for controlled delivery of anticancer drugs
    241. Kimberly Ann V. Zubris; Efficacy of paclitaxel-eluting expansile nanoparticles inbreast cancer
    242. Kimberly Ann V. Zubris; Paclitaxel-loaded nanoparticles prevent malignant peritoneal mesothelioma in vivo
    243. Xiang-Hong Peng; Reducing non-specific toxicity of cisplatinin head and neck cancer by targeted therapy using cisplatin-heparin-folic acid nanoparticles
    244. Gwi-Moon Seo; Proteome analysis after attenuation of mouse melanomas by stem cell targeted magnetic hypothermia

    245. Robert L. MacCuspie; Surface characterization of gold and silver nanoparticles to predict fate and behavior in biomedical applictions
    246. Mohsen Soleimani; Reversible pH-induced microphase separation probed by fluorescence resonance energy transfer in polymer-polymer composite nanopartiles
    247. Kerri-Ann Hue; Particle size and density measurement using ultra-high-resolution mass sensors

    Photodynamic & EM Therapy
    248. Raja Shekar Rachakatla; An in vivo experimental study of mouse melanoma therapy by neural stem cell-targetted magnetic hyperthermia
    249. Sivasai Balivada; Homing studies of monoytes, endothelial cells, andrat umbilical cord cells loaded with Fe/Fe3O4 core/shell magnetic nanoparticles in a subcutaneous mouse melanoma model
    250. Martina Koneracka; Interaction of magnetic fluids with amyloid aggregates
    251. Vlasta Zavisova; Magnetic nanospheres carrying anticancer drug
    252. Ran Ji Yoo; Radiosensitizing effect of paclitaxel-loaded pH-sensitive block copolymer micelles
    Seong-Yun Jeong; Radiosensitization effects of polymeric nanoparticle-sirolimus on human cancer cells
    254. Jinesh Shah; Nanostructured core-shell ferrites as a magnetic carrier for targeted drug delivery and biomedical applications

    Surface Modification
    255. Joel Zazyczny; Cyclic azasilanes: Vapor phase functionalization of nanoparticles
    256. Rasmus I. Joelck; Quantification of liposome functionalization by a fluorogenic 1,3-dipolar cycloaddition reaction
    257. Jussi Rytkönen; Biodistribution of PEGylated and algiante/chitosan shielded nanoparticles
    258. Ammar T. Qureshi; Bacterial biofilm reduction using silver nanocomposites on orthopedic implants
    259. Kristina Eleršič; Adhesion of streptavidin onto magnetic beads

    Encapsulation & Controlled Release
    260. Martin Loew; Controlled release in time and space: Assembly of nanocontainers on a carrier system via DNA hybridization
    261. Erhan I. Altinoglu; Tailoring calcium phosphate nanoparticles for in vivo imaging and drug delivery applications
    262. Mark A. Bewernitz; Generation of â"€"œsoft-hardâ"€" core-shell particles for controlled release
    263. Joohee Jung; Development of low immunogenic bio-nanocapsules
    264. Hakan Kaygusuz; Controlled release of proteins from doped alginate hydrogels
    265. Michal Pellach; The encapsulation of hydrophobic light-emitting dyes and amphiphilic fluorescein into polystyrene microspheres of narrow size-distribution
    318. Toshiro Kaneko; Monodispersed nanoparticles synthesized inside carbon nanotubes using gas-liquid interfacial plasmas

    Diagnostics & Imaging
    266. Hong Yan Liu; Generation of multi-color monovalent quantum dots for tumor marker profiling
    267. Adam Shuhendler; Stealth solid lipid nanoparticles encapsulating lead selenide quantum dots for whole animal near infrared fluorescence imaging
    268. Shivang R. Dave; Development of highly luminescent robust quantum dot-based reporter barcodes for ultrasensitive detection of cancer biomarkers
    269. Y. Andrew Wang; Uptake of quantum dots by plants
    270. Oscar J. Santiesteban; Small-molecule-conjugated nanosensors for the sensitive detection of toxins via magnetic relaxation
    271. Ariane Beaupré; Development of lanthanide ion-based luminescent nanoparticles
    272. Xiaoge Hu; Modification of gold nanorods as stable contrast agents
    273. Xuan Zhang; Ultra-small Au nanoparticles in cells
    274. Thomas R. Morris II; Synthesis and characterization of zinc blend luminescent nanoparticles
    Poster Session P2 (Monday, 1800-1930)
    Session Chair: John Texter, Eastern Michigan University

    Nanoparticles & Hydrogels
    275. Y. Andrew Wang; Quantum dots for bioscience
    276. Y. Andrew Wang; Iron oxide nanocrystals for bioscience
    277. Stephanie Bosselmann; Formulation and characterization of itraconazole nanoparticles made by advanced evaporative precipitation into aqueous solution
    278. Stephanie Bosselmann; Enhanced stability of amorphous ketoprofen made by rapid freezing through the deposition of hydrophobic plasma-polymerized films
    279. Hung Pham; Polymer nanoparticles as nanoformulation agents

    280. Zifu Li; Preparation and application of microgel-stabilized high inernal phase emulsions
    281. Sheng Qi; An investigation into the effect of the addition of hydrophilic polymers on the physicochemical properties of self-emulsifying drug delivery systems for poorly water-soluble drugs

    General Papers
    282. Gregory R. Hayes; Design and fabrication of nanoparticle enabled mesoscale surgical instruments
    283. Igor Zhitomirsky; Colloidal processing of nanoparticles and composites for biomedical applications
    284. Xiaoling Wei; Interactions between a silica particle and a hydrophilic surface in a thermoresponsive triblock copolymer solution
    285. Yoon Kyun Hwang; A substitution method of skin permeation systems by polymeric membranes
    286. Tawatchai Charinpanitkul; Removal of aqueous dye pollutants using carbon nanoparticles synthesized by co-pyrolysis method
    287. Hye Sung Kim; Corrosion resistance properties of CaO-SiO2: Nanocomposites on Mg alloys by a sol-gel dip coating technique
    288. Trevor Goff; Effect of silicate doping on dissolution of calcium phosphate nanoparticles
    289. Songtao Yang; Using nanoparticles as flotation collectors

    290. Regine Hedderich; Health related aspectsof nanomaterials
    291. Amra Tabakovic; Cytotoxicity of calcium phosphosilicate nanoparticles in human cancer cells: Effects of surface functionaities and particle size
    292. Lian-Yan Wang; Effects of particle size in macrophage responses
    293. Mi Young Lee; Gene expression profiling of aluminum nanoparticle toxicity in human neruoblastoma cells
    294. Mi Young Lee; Airborne nanoparticle-induced differential protein expression profile of human bronchial epithelial cells 295. Z. Q. Chu; Cellular uptake and cytotoxicity of silica nanoparticles
    296. Lionel Maurizi; Titanate nanotubes as new carriers in the field of cardiovascular diseases: Synthesis, functionalization, internalization and toxicity
    297. Jean-Francois Berret; Interactions between sub-10 nm iron and cerium oxide nanoparticles and 3T3 fibroblasts: the role of the coating and aggregation state

    siRNA & Gene Delivery
    298. Deepa Bedi; siRNA delivery into cancer cells by phage-fusion proteins
    299. Paige K. Brown; Antisense silver nanoscale drug delivery system for photoactivated gene silencing
    300. Olisa Pinto; Encapsulation of RNA in calcium phosphosilicate nanosomposite particles for cancer treatments
    301. Phei Er Saw; Efficient liposomal nanocarrier-mediated oligodeoxynucleotide delivery involving dual use of a cell-penetrating peptide as packaging and intracellular delivery agent
    302. Meenakshi Malhotra; Surface functionalized chitosan nanoparticles for gene delivery

    Powder & Inhalation
    303. Heiko Schiffter; Spray freeze drying of proteins and vaccines: A thorough investigation of drug stability during nano- and microparticle manufacture
    304. Buket Aksu; Optimization studies for making free-flowing compactable powder and granule containing ramipril with high concentration of HPMC at 60C and 0.5% humidity
    305. Hongshi Yu; Enabled formulations for inhaled programs in lead optimization

    Encapsulation & Controlled Release
    306. Ajay J. Khopade; Novel vesicles of paclitaxel
    307. Han Do Ghim; Protection of functional foodstuff-driven colorants from environment by isolation with silica nanocapsules â"€"“ A model study
    308. Erik Rytting; In vitro and in vivo performance of biocompatible negatively-charged salbutamol-loaded nanoparticles
    309. Mei Han Ng; Encapsulated palm tocotrienols for targeted delivery
    319. Hanjiang Dong; Rapid fabrication of high-surface area core-shell nanoparticles using a layer-by-layer approach

    Diagnostics & Imaging
    310. Jinho Park; Amphiphilic polymer coated SPION with antibiofouling properties for MRI cancer imaging
    311. Matthieu F. Dumont; Surface modified gadolinium phosphate nanoparticles as MRI contrast agents
    312. Ja Young Park; Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agents
    313. Myung Ju Baek; Water soluble and Mn(II) ion surface doped ultrasmall gadolinium oxide nanoparticles for a highly sensitive T1 MRI contrast agent
    314. Dongkyu Kim; A drug loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer
    315. Fernanda Sousa; Coated nanogold and the brain â"€"“ A multimode microscopy distribution study from mouse to cell
    316. Myriam Moussaoui; Use of ZnS nanopowders for bioapplications
    317. Myriam Moussaoui; Use of ZnS nanoparticle emissions for cell labeling


    Attendee Type Through 19 May
    Industrial US$1005
    Academic/Government US$805
    Full-time Student US$705
    Accompanying Person US$350

    On-Site Registration US$1105
    Accompanying Person US$350

    Registration Form

    Next Registration Deadline is 19 May 2010

    Hotel Information

    Regal Sun Resort
    1850 Hotel Plaza Boulevard
    Lake Buena Vista, Florida
    Phone: 1-800-624-4109 or 1-407-828-4444
    Fax: (407) 828-8192 Attention Reservations

    A limited room block is available on site at the Regal Sun Resort at the highly favorable rate of US$95 per night (plus 12.5% taxes) at single or double occupancy. Situated in the Disney World Resort, this site provides urban walking access to diverse international cuisine, shopping, and world famous attractions, while also providing quiet and tropical isolation from the tourist hustle and bustle.

    Registration Form

    Next Registration Deadline is 19 May 2010


    A series of one day short courses will be presented on Friday and Saturday preceding the start of the conference. A small number of rooms at the Regal Sun Resort at the conference rate of $95 (plus 12.5% taxes) are available for the evenings of 20 and 21 May.

    Friday, May 21st
    Introduction to Colloidal Dispersions

    Saturday, May 22nd
    Introduction to Colloidal Dispersions (continued)
    Surfaces Modification Chemistries for Particles and Interfaces

    Workshop Registration Form

    Corporate Sponsor

  • NanoSight, Ltd.
  • Exhibitors

    Particles 2010 HomeParticles 2010 Home ProgramProgram Registration InfoRegistration Information Go to Registration FormRegistration Form
    Go to Abstracts PageAbstract Submission Hotel InfoHotel Accomodations Go to ExhibitngExhibiting Workshop InfoWorkshops Go to DirectionsDirections
    © 2004-2009 Particles Conference
    tel 1-585-288-5913; fax 1-585-482-7795